ACB

DRUG4 trials

Sponsors

Cedars-Sinai Medical Center, NYU Langone Health, Changhai Hospital, Radboud Universitair Medisch Centrum

Conditions

AnalgesiaHIVPain, PostoperativePancreatic Diseases

Phase 4

Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO

RecruitingNCT06952556

NYU Langone HealthAnalgesia

Start: 2025-04-28End: 2027-06-28Target: 100Updated: 2026-02-25

Unknown Phase

Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block

CompletedNCT02548104

Cedars-Sinai Medical CenterPain, Postoperative

Start: 2017-10-01End: 2023-11-06Updated: 2025-06-19

Relative bioavailability study to investigate a potential interaction between dolutegravir (DTG) and tenofovir alafenamide fumarate/emtricitabine (F/TAF) administered as paediatric tablet formulations.

Active, not recruitingNL-OMON51616

Radboud Universitair Medisch CentrumHIV

Start: 2022-11-02Target: 16Updated: 2024-04-15

The 22G Franseen Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy

Not yet recruitingNCT07023549

Changhai HospitalPancreatic Diseases

Start: 2025-07-01End: 2027-05-31Target: 270Updated: 2025-06-17